Neurocrine Biosciences Financials

Values in thousands	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Revenue	$627,700	$622,100	$590,200	$515,299
Gross Profit	618,400	614,100	574,600	502,499
EBITDA	152,100	191,300	155,200	111,500
EBIT	145,000	184,800	147,900	105,300
Net Income	103,100	129,800	65,000	43,400
Net Change In Cash	627,700	622,100	590,200	515,299
Free Cash Flow	235,200	149,900	52,999	119,100
Cash	233,000	349,100	139,700	396,300
Basic Shares	103,700	104,300	103,900	103,600

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,355,300	$1,887,100	$1,488,700	$1,133,500
Gross Profit	2,321,300	1,847,400	1,465,500	1,119,200
EBITDA	610,100	358,000	264,600	218,700
EBIT	583,000	336,700	249,000	207,800
Net Income	341,300	249,700	154,500	89,600
Net Change In Cash	2,355,300	1,887,100	1,488,700	1,133,500
Cost of Revenue			-72,000	153,700
Free Cash Flow	557,200	361,600	322,900	233,100
Cash	233,000	251,100	262,900	340,800
Basic Shares	103,700	101,000	98,900	97,900